Yu, Junhui <br/><br/>
CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.  [electronic resource] 

 -  Cell death & disease  01 2019 
 - 26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/s41419-018-1263-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Axin Protein--metabolism<br/>CDX2 Transcription Factor--genetics<br/>Caco-2 Cells<br/>Carcinogenesis--metabolism<br/>Cell Cycle Checkpoints<br/>Cell Proliferation<br/>Colonic Neoplasms--metabolism<br/>Cyclin D1--metabolism<br/>Female<br/>Gene Knockdown Techniques<br/>Glycogen Synthase Kinase 3 beta--metabolism<br/>HT29 Cells<br/>Heterocyclic Compounds, 3-Ring--pharmacology<br/>Heterografts<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Proto-Oncogene Proteins c-myc--metabolism<br/>Pyridines--pharmacology<br/>Pyrimidines--pharmacology<br/>Transfection<br/>Tumor Burden<br/>Wnt Proteins--antagonists & inhibitors<br/>Wnt Signaling Pathway<br/>beta Catenin--antagonists & inhibitors